Valvular & structural heart diseaseCohort study
Atrial Secondary Tricuspid Regurgitation
- Registry-based cohort study
- multicentre registry (EuroTR)
Authors' conclusion
A-STR is a common phenotype of STR and is associated with effective TR reduction and symptomatic reduction after T-TEER.
Study context
- Population
- Patients undergoing T-TEER for secondary tricuspid regurgitation, EuroTR registry, 2016–202250% women
- Participants
- 641 patients
- Exposure
- Atrial secondary tricuspid regurgitation (A-STR) vs nonatrial STR after T-TEER
- Outcome
- Survival free from HF hospitalization
- Follow-up
- 2 years
Main finding
As reported in the abstract
P < 0.001
Observational data: associations, not effects.
Secondary outcomes
| Outcome | Values | P value |
|---|---|---|
| Procedural TR reduction (TR ≤2+) | A-STR 86.9% · Nonatrial STR 80.4% | P = 0.005 |
| NYHA class ≥III · latest available follow-up | A-STR 38% · Nonatrial STR 46% | P = 0.033 |
Prevalence of A-STR
- Overall prevalence of A-STR
- 31%
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Atrial Secondary Tricuspid Regurgitation. JACC Cardiovasc Interv. Published 9 December 2024. doi:10.1016/j.jcin.2024.10.028
Summarised from the published abstract; every number is checked against it